CatherineSun JooKimMD

Regional Network Medical Director, Radiation Oncology, Penn Medicine at University of Pennsylvania Health System Medical Director, Penn Medicine Virtua Radiation Oncology - Voorhees and Moorestown

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Office
200 Bowman Drive
Suite D190
Voorhees, NJ 08043
Phone+1 856-247-7330

Fax+1 856-247-7331
Is this information wrong?

Summary

Dr. Catherine Kim is a radiation oncologist in Voorhees, NJ and is affiliated with multiple hospitals in the area, including Virtua Memorial, Virtua Marlton, Virtua Berlin, Virtua Voorhees, and Penn Presbyterian Medical Center. She received her medical degree from Sidney Kimmel Medical College and has been in practice 15 years. She also speaks multiple languages, including Korean. She is experienced in breast cancer, lung cancer, gynecologic cancer, lymphoma, and brain metastases.

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2003 - 2007
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2002 - 2003
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2002

Certifications & Licensure

NJ State Medical License 2007 - 2025
PA State Medical License 2006 - 2024
American Board of Radiology Radiation Oncology

Clinical Trials

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2014 Oct 27
Active, not recruiting
Phase 2
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer Start of enrollment: 2014 Aug 01
Completed
Phase 1

Publications & Presentations

PubMed

Images in clinical medicine. Lymphadenopathy.
Catherine S Kim, Maria Werner-Wasik> ;The New England Journal of Medicine. 2008 Oct 9

Abstracts/Posters

“Impact of Pretreatment Tumor Size and Lymph Nodes on Pathologic Complete Response and Survival in a Prospective Trial of Chemoradiation for Locally Advanced Rectal Ca...
Kim CS, Anne PR, Mitchell EP, Pequignot EC, Palazzo JP, Goldstein SD, Isenberg GA, Curran WJ Jr., Int. J. Radiat. Oncol. Biol. Phys. 63 (2) S: 164-165, 2005.
“Tumor size as a predictor of pathologic complete response (pCR) and survival in a prospective trial of chemoradiation for locally advanced rectal cancer.”
Kim CS, Anne PR, Mitchell EP, Palazzo J, Pequignot E, Fishel R, Goldstein SD, Isenberg GA, Curran W., Proc Am Soc Clin Oncol 23: 16S, 2005.
“Predicted Germline BRCA1/BRCA2 Mutations and Second Primary Ipsilateral Breast Cancers in Young Women with Pure Ductal Carcinoma in-situ treated with Breast Conservin...
Kim CS, Gumbs AA, Komarnicky L, Carter D, Hutter R, Palazzo JP, McCue PA, Goodman R, Haffty BG, Rebbeck TR, Weber BL, Turner BC., Int. J. Radiat. Oncol. Biol. Phys. 48 (3) S: 142-143, 2000.

Press Mentions

2022 N.J. Top Cancer Doctors Deliver Quality and Compassionate Care, Close to HomeJune 16th, 2022
N.J.’s 2021 Top Cancer Doctors Lead Charge to Help Patients Thrive and Survive After PandemicJune 17th, 2021

Committees

Member, Thoracic Program Leadership Steering Committe 2013 - Present
Member, Breast Program Leadership Steering Committee 2012 - Present
Scientific Abstract Reviewer, ASTRO Annual Meeting - Breast Track Committee 2012 - Present